Table 1 Mapping the collection of PSG mutations using pairs of dominant markers
EstimatedActual
mutationAllelescMcytoDfcyto
psg82left of R61ADf(3L)BSC36261C
psg281left of R61ADf(3L)BSC36261C
psg2a22566CDDf(3L)Exel610564D
psg5a23467EFDf(3L)Exel611266B
psg15128.167BDf(3L)BSC38866B
psg23123.566CDf(3L)BSC67367BD
psg16140.770CDf(3L)ED445768A
psg19148.385ABDf(3L)ED21771B
psg3a244.472DDf(3L)BSC77472D
psg27143.872ADf(3L)ED460672D
psg21143.872ADf(3L)BSC77575E
psg22152.688BDf(3L)BSC77575E
psg1015588FDf(3L)ED22976A
psg14145.673FDf(3L)ED22976D
psg26150.587ADf(3L)ED510082D
psg4348.785DDf(3R)Tpl1083E
psg9b144.272CDf(3R)BSC46685A
psg20144.872FDf(3R)BSC50785D
psg6250.386FDf(3R)BSC48687D
psg7a36691FDf(3R)Exel617890F
psg25169.592FDf(3R)ED593892A
psg29163.891CDf(3R)BSC67793D
psg11170.393BDf(3R)BSC67793F
psg24180.195ADf(3R)BSC61994E
psg13179.895ADf(3R)ED618795F
psg18186.896CDf(3R)Exel620396E
psg171right of Pr99ADf(3R)BSC50199A
psg121right of Pr100DDf(3R)BSC50399F
  • Each of the 28 complementation groups, and the number of alleles in each group, are indicated in the first and second columns, respectively. The third column displays the genetic map location obtained by using the pairs of dominant markers for recombination analysis; the fourth column displays the corresponding estimated cytological location. The fifth and sixth columns represent the deficiencies that fail to complement each complementation group and their cytological location, respectively. The first two mutants (psg8 and psg28) map to the left of R, and the last two mutant (psg17 and psg12) map to the right of Pr. The location of these four mutations was based on the orientation of splits because they were not inside any of the pairs used; however, given that these regions are covered by a small number of DK3 stocks, deficiency mapping was straight forward. PSG, persistent salivary gland.

  • a Recombination results reported by Wang et al. 2008.

  • b Recombination results reported in Ihry et al. 2012.